Aapatinib plus paclitaxel and cisplatin/carboplatin versus paclitaxel and cisplatin/carboplatin in the treatment of stage IVB, recurrent or persistent cervical cancer a prospective, randomized, multicenter, phase II clinical study
Latest Information Update: 10 Sep 2018
At a glance
- Drugs Carboplatin (Primary) ; Cisplatin (Primary) ; Paclitaxel (Primary) ; Rivoceranib (Primary)
- Indications Adenocarcinoma; Carcinoma; Cervical cancer; Squamous cell cancer
- Focus Therapeutic Use
Most Recent Events
- 10 Sep 2018 New trial record